KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 107 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 12.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $11,088,000 | +32.3% | 147,892 | +32.8% | 0.01% | +62.5% |
| Q2 2015 | $8,384,000 | +451.9% | 111,327 | +267.6% | 0.01% | +300.0% |
| Q1 2015 | $1,519,000 | +59.2% | 30,282 | +10.1% | 0.00% | +100.0% |
| Q4 2014 | $954,000 | +127.1% | 27,502 | +114.4% | 0.00% | – |
| Q3 2014 | $420,000 | -18.3% | 12,829 | -4.4% | 0.00% | – |
| Q2 2014 | $514,000 | -17.0% | 13,417 | -13.8% | 0.00% | -100.0% |
| Q1 2014 | $619,000 | -8.7% | 15,568 | -14.3% | 0.00% | 0.0% |
| Q4 2013 | $678,000 | – | 18,170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,810,518 | $71,986,000 | 2.98% |
| Redmile Group, LLC | 443,326 | $17,627,000 | 2.10% |
| AlpInvest Partners B.V. | 22,224 | $884,000 | 2.04% |
| SENZAR ASSET MANAGEMENT, LLC | 89,500 | $3,558,000 | 1.88% |
| Aureus Asset Management, LLC | 136,305 | $5,419,000 | 1.39% |
| PFM Health Sciences, LP | 1,003,492 | $39,899,000 | 0.72% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $7,016,000 | 0.68% |
| Ghost Tree Capital, LLC | 25,000 | $994,000 | 0.59% |
| HAMILTON LANE ADVISORS LLC | 30,264 | $1,203,000 | 0.48% |
| Pentwater Capital Management LP | 390,000 | $15,506,000 | 0.41% |